3rd Quarter - Report

STANTON PARK GROUP for BARR LABORATORIES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Patent Reform

LobbyistCovered position, as disclosed
BRIAN CAVEY —
JAMES DERDERIAN —
ANDREW HALATAEI —
ERIN STRAWN —
ASHLIE VAN METER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Proposed Bilateral Tax Treaty with Croatia

LobbyistCovered position, as disclosed
JAMES DERDERIAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Consumer Issues/Safety/Products CSP

Generic Drug Settlement Issues

LobbyistCovered position, as disclosed
BRIAN CAVEY —
JAMES DERDERIAN —
ANDREW HALATAEI —
ERIN STRAWN —
ASHLIE VAN METER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Generic Biologics, HR 1956; S. 1695; Hr 1038; S. 623; HR 5629; FDA Reform

LobbyistCovered position, as disclosed
BRIAN CAVEY —
JAMES DERDERIAN —
ANDREW HALATAEI —
ERIN STRAWN —
ASHLIE VAN METER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1956 (110th), H.R. 5629 (110th), H.R. 1038 (110th), S. 1695 (110th), S. 623 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.